Clinical trials: Conduction Disturbances

Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative)

Safety of Argatroban Infusion in Conduction Disturbances

• Completed
• Age: 18 years and older
• Phase 4
• Results posted

To determine change of QTc interval during intravenous argatroban infusion in patients undergoing percutaneous coronary intervention (PCI)

Trial name

SAICoDis (NCT05740371)

Testing

Argatroban

Where

2 sites in Germany

Volunteers

50 people

Sponsor

Tanabe Pharma GmbH